MURALIDHAR YERRAMADHA: Open Payments
NPI 1609184027 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 37 payments from 13 companies in 2025. Trend: 2023 $223 · 2024 $481 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $122 |
| Novo Nordisk Inc | 5 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Abbott Laboratories | 2 | $43 |
| Amgen Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| PFIZER INC. | 1 | $24 |
Products named: Kerendia, UBRELVY, Rybelsus, XIFAXAN, FREESTYLE LIBRE 3, OTEZLA, MOUNJARO, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
